BFM
EVH icon

Boothbay Fund Management’s Evolent Health EVH Stock Holding History

Boothbay Fund Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
21,583
-25,644
-54% -$98.3K ﹤0.01% 2031
2026
Q1 		$108K Sell
47,227
-121,656
-72% -$386K ﹤0.01% 1868
2025
Q4 		$676K Buy
168,883
+137,821
+444% +$766K 0.01% 985
2025
Q3 		$263K Buy
+31,062
New +$301K ﹤0.01% 1515
2020
Q1 		– Sell
-93,620
Closed -$847K – 908
2019
Q4 		$847K Buy
+93,620
New +$761K 0.07% 357

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Boothbay Fund Management's EVH Position: Q2 2026 in Review

Boothbay Fund Management reduced its Evolent Health (EVH) stake by 54% in Q2 2026, selling an estimated $98.3K and leaving 21,583 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

Boothbay Fund Management first reported a position in EVH in Q4 2019 and has held it in 5 quarters since. The position peaked at $847K in Q4 2019. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Boothbay Fund Management held 21,583 shares of Evolent Health worth $117K as of Q2 2026.
  • Boothbay Fund Management sold 25,644 Evolent Health shares in Q2 2026, an estimated $98.3K.
  • Evolent Health made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2031 holding.
  • Boothbay Fund Management first reported a position in Evolent Health in Q4 2019 and has held it in 5 quarters since.
  • Boothbay Fund Management's Evolent Health position peaked at $847K in Q4 2019.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.